Role of nav-anna as a causative factor for Prediabetes.

Aetio pathological study of Nava godhuma and purana godhuma in prameha purvarupa in context of Prediabetes.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/04/041618

Enrollment

Registered

2022-04-04

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R739- Hyperglycemia, unspecified Health Condition 2: E889- Metabolic disorder, unspecified Health Condition 3: E889- Metabolic disorder, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: (1)-Patients who are fulfilling the conditions of Prediabetes according to who. (2)-HbA1c between 42-47 mmol/mol. (3)-Fasting blood sugar 100-126 mg/dl. (4)-Post prandial blood sugar 140-180 mg/dl.

Exclusion criteria

Exclusion criteria: (1) Patients having diabetes Mellitus type 1,type 2 and other malignant disorders. Pregnant women. (2)Patients with history of critical (3)cardiovascular disease. (4)Patients with major complications and in requirement of emergency treatment.

Design outcomes

Primary

Measure	Time frame
(1) Fasting Blood Sugar (2) hba1cTimepoint: (1) At the time of enrollment (2) After 3 months.	—

Secondary

Measure	Time frame
To observe the level of impact of nav-anna (godhuma) in FBS altering in survey. Timepoint: Retrospectively.	—

Countries

India

Contacts

Public ContactDivya pathak

NIA

drsksm31@rediffmail.com9414361874

Outcome results